SIE aderisce al protocollo di autenticazione
SIE è affiliata a
Aggiornamento Clinico Scientifico
Effect of surgery vs observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)
a cura di Massimo Procopio
Lundstam K, Heck A, Godang K, Mollerup C, Baranowski M, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Bollerslev J
J Bone Miner Res. 2017, DOI 10.1002/jbmr.3177
LEGGI TUTTO
Aggiornamento Clinico Scientifico
High-dose and high-frequency lanreotide autogel in acromegaly: a randomized, multicenter study
a cura di Laura Trementino
Giustina A, Mazziotti G, Cannavò S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E.
J Clin Endocrinol Metab. 2017Apr 17. doi: 10.1210/jc.2017-00142. [Epub ahead of print]
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
a cura di Flavia Prodam
Mariño E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J, McKenzie C, Kranich J, Oliveira AC, Rossello FJ, Krishnamurthy B, Nefzger CM, Macia L, Thorburn A, Baxter AG, Morahan G, Wong LH, Polo JM, Moore RJ, Lockett TJ, Clarke JM, Topping DL, Harrison LC, Mackay CR.
Nat Immunol. 2017;18:552-562.
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Meta-Analysis of the association between phosphodiesterase inhibitors (PDE5Is) and risk of melanom
a cura di Daniele Gianfrilli
Loeb S, Ventimiglia E, Salonia A, Folkvaljon Y, Stattin P.
JNCI J Natl Cancer Inst (2017) 109(8): djx086
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years
a cura di Anna Maria De Bellis
Wang S, Wang L, Yao Y, Feng F, Yang H, Liang Z, Deng K, You H, Sun J, Xing B, Jin Z, Wang R, Pan H, Zhu H.
Clin Endocrinol (Oxf). 2017 Apr 19.
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Mutations in the human ROBO1 gene in pituitary stalk interruption syndrome
a cura di Giuseppe Bellastella
Bashamboo A, Bignon-Topalovic, J, Moussi N, McElreavey K, Brauner R
J Clin Endocrinol Metab. 2017 Apr 11. doi: 10.1210/jc.2016-1095
LEGGI TUTTO
Aggiornamento Clinico ScientificoEffects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
a cura di Marco Giorgio Baroni
Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, Hayward RA, Craven T, Coleman RL, Chalmers J; Collaborators on Trials of Lowering Glucose (CONTROL) group.
Lancet Diabetes Endocrinol. 2017 Jun;5(6):431-437.
LEGGI TUTTO
Aggiornamento Clinico Scientifico
The type 3 deiodinase is a critical determinant of appropriate thyroid hormone action in the developing testis
a cura di Daniele Gianfrilli
Martinez M E, Karaczyn A, Stohn J P, Donnelly W T, Croteau W, Peeters R P, Galton V A, Forrest D, St. Germain D, Hernandez A.
Endocrinology, 2016, 157(3):1276–1288
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
a cura di Marco Giorgio Baroni
Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJ, Solomon SD.
Lancet Diabetes Endocrinol 2017 Mar 17.
LEGGI TUTTO
Aggiornamento Clinico Scientifico
Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction?
a cura di Anna Maria De Bellis
Sakar MN, Unal A, Atay AE, Zebitay AG, Verit FF, Demir S, Turfan M, Omer B.
J Obstet Gynaecol. 2016;36(2):213-7.
LEGGI TUTTO
Napoli [...]
Stoccolma [...]
Roma [...]
